Key result
Ad-36 seropositivity linked to ~166% higher odds of obesity and low HDL in Mexican children.
Why the study?
The relationship between Adenovirus-36 seropositivity and obesity with metabolic profile alterations in children was previously established but required further evaluation in Mexican children.
Is Adenovirus-36 seropositivity associated with obesity and altered metabolic profiles in children?
Case-Control (n=157)
Is Adenovirus-36 seropositivity associated with obesity and altered metabolic profiles in children?
Adenovirus-36 seropositivity is significantly associated with obesity and low HDL cholesterol levels in Mexican children, suggesting a potential viral link to pediatric adiposity and metabolic risk.
Should not yet change pediatric obesity care; hypothesis-generating for Ad-36 in Mexican children pending replication.
The human adenovirus 36 (Ad-36) is causally and correlatively associated in animals and humans, respectively, with increased adiposity and altered metabolic profile. In previous studies, the relationship between Ad-36 seropositivity with obesity was established in adults and children. We evaluated the association of positive antibodies to Ad-36 with obesity and metabolic profile in Mexican children. Seventy-five children with normal-weight and 82 with obesity were studied in this research. All children had a clinic assessment which included weight, height, body circumferences, and skinfold thickness. Laboratory analyzes included triglycerides, total cholesterol, high-density lipoprotein, low-density lipoprotein, and glucose and insulin levels. An enzyme-linked immunosorbent assay (ELISA) was used to determine the antibodies to Ad-36 in the serum samples. The overall Ad-36 seroprevalence was 73.9%. Ad-36 seropositivity had a higher prevalence in obese children than in normal weight group (58.6 versus 41.4%, P = 0.007). Ad-36 seropositivity was associated with obesity (OR = 2.66, P = 0.01) and high-density lipoprotein <40 mg/dL (OR = 2.85, P = 0.03). The Ad-36 seropositive group had greater risk of 4 metabolic abnormalities compared with those children without none alteration. In summary, Ad-36 seropositivity was associated with obesity and low HDL-c levels in the sample of children studied.
No takes yet. Share an insight, caveat, or question.
Parra‐Rojas et al. (2013) conducted a case-control in Obesity (n=157). Ad-36 seropositivity vs. Ad-36 seronegativity was evaluated on Obesity (OR 2.66, p=0.01). Ad-36 seropositivity was significantly associated with obesity (OR 2.66, P=0.01) and low HDL cholesterol (OR 2.85, P=0.03) in Mexican children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: